The circadian clock protein BMAL and post-translational regulation of ENaC in the kidney
肾脏中生物钟蛋白 BMAL 和 ENaC 的翻译后调节
基本信息
- 批准号:10662317
- 负责人:
- 金额:$ 33.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-07-01 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
ABSTRACT
The epithelial sodium channel (ENaC) expressed in the distal tubule and collecting duct
is responsible for the final regulation of sodium reabsorption by the kidneys. The
myristoylated alanine-rich C kinase substrate (MARCKS) plays an important role as an
adaptor protein between the anionic phospholipid PIP2 and ENaC. Both ENaC and
MARCKS are positively regulated by the protease cathepsin B. First, our preliminary
data demonstrate renal ENaC activity and MARCKS protein expression are positively
regulated by the circadian protein BMAL1. Second, our preliminary data show alpha-1
antitrypsin is increased in the BMAL1 knockout mouse kidney compared to the kidney of
wild-type mice sacrificed at the same time. Third, our preliminary data show alpha-1
antitrypsin is expressed in the kidney and it strongly inhibits cathepsin B activity and
contributes to blood pressure regulation. In this project we will test our hypothesis that
the association between renal ENaC and MARCKS, and their function at the apical
plasma membrane negatively correlates with alpha-1 antitrypsin expression in a
circadian dependent manner. We will perform experiments to investigate proteolysis
and apical membrane expression of ENaC and MARCKS, ENaC activity, sodium
handling, and blood pressure using male and female BMAL1 knockout mice, alpha-1
antitrypsin knockout mice, alpha-1 antitrypsin overexpressing mice, cathepsin B
knockout mice, and wild-type control mice. The successful completion of our proposed
studies for this project will reveal new mechanisms underlying the role of BMAL1 in the
regulation of renal ENaC and MARCKS and blood pressure control. Our long term goal
is to provide a better understanding for the pathogenesis of essential hypertension that
can potentially lead to novel drug targets and therapeutics.
抽象的
在远端小管中表达并收集管道的上皮钠通道(ENAC)
负责最终调节肾脏钠的重吸收。这
肉豆蔻酰化富含丙氨酸的C激酶底物(MARCKS)作为一个重要作用
阴离子磷脂PIP2和ENAC之间的衔接蛋白。 enac和
马克克人受蛋白酶组织蛋白酶B的积极调节。首先,我们的初步
数据表明肾脏ENAC活性和MARCKS蛋白表达是积极的
由昼夜节律BMAL1调节。第二,我们的初步数据显示Alpha-1
与肾脏相比
野生型小鼠同时牺牲了。第三,我们的初步数据显示Alpha-1
抗胰蛋白酶在肾脏中表达,并强烈抑制组织蛋白酶B活性和
有助于血压调节。在这个项目中,我们将测试我们的假设
肾脏ENAC和MARCKS之间的关联及其在顶端的功能
质膜与A中的α-1抗胰蛋白酶表达负相关
昼夜节律的方式。我们将进行实验以研究蛋白水解
ENAC和MARCK的顶膜表达,ENAC活性,钠
使用雄性和雌性BMAL1基因敲除小鼠的处理和血压,Alpha-1
抗胰蛋白酶基因敲除小鼠,α-1抗胰蛋白酶过表达小鼠,组织蛋白酶B
敲除小鼠和野生型对照小鼠。我们提议的成功完成
该项目的研究将揭示BMAL1在
调节肾脏ENAC和MARCKS以及血压控制。我们的长期目标
是为基本高血压的发病机理提供更好的理解
可能会导致新颖的药物靶标和治疗剂。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Metformin Alleviates Diabetes-Associated Hypertension by Attenuating the Renal Epithelial Sodium Channel.
- DOI:10.3390/biomedicines11020305
- 发表时间:2023-01-21
- 期刊:
- 影响因子:4.7
- 作者:
- 通讯作者:
Transgenic Mice Overexpressing Human Alpha-1 Antitrypsin Exhibit Low Blood Pressure and Altered Epithelial Transport Mechanisms in the Inactive and Active Cycles.
- DOI:10.3389/fphys.2021.710313
- 发表时间:2021
- 期刊:
- 影响因子:4
- 作者:Liu LP;Gholam MF;Elshikha AS;Kawakibi T;Elmoujahid N;Moussa HH;Song S;Alli AA
- 通讯作者:Alli AA
Human Alpha-1 Antitrypsin Attenuates ENaC and MARCKS and Lowers Blood Pressure in Hypertensive Diabetic db/db Mice.
- DOI:10.3390/biom13010066
- 发表时间:2022-12-29
- 期刊:
- 影响因子:5.5
- 作者:
- 通讯作者:
Dapagliflozin Treatment Augments Bioactive Phosphatidylethanolamine Concentrations in Kidney Cortex Membrane Fractions of Hypertensive Diabetic db/db Mice and Alters the Density of Lipid Rafts in Mouse Proximal Tubule Cells.
- DOI:10.3390/ijms24021408
- 发表时间:2023-01-11
- 期刊:
- 影响因子:5.6
- 作者:Gholam, Mohammed F.;Liu, Lauren P.;Searcy, Louis A.;Denslow, Nancy D.;Alli, Abdel A.
- 通讯作者:Alli, Abdel A.
Tempol treatment normalizes membrane expression of epithelial transport proteins in the kidney of salt-loaded hypertensive diabetic db/db mice.
Tempol 治疗可使盐负荷高血压糖尿病 db/db 小鼠肾脏中上皮转运蛋白的膜表达正常化。
- DOI:
- 发表时间:2023
- 期刊:
- 影响因子:2.2
- 作者:Dogan,YunusE;Bala,Niharika;Chacko,KevinM;Tuna,KubraM;Alli,AbdelA
- 通讯作者:Alli,AbdelA
共 12 条
- 1
- 2
- 3
Abdel Ayube Alli的其他基金
The circadian clock protein BMAL and post-translational regulation of ENaC in the kidney
肾脏中生物钟蛋白 BMAL 和 ENaC 的翻译后调节
- 批准号:1020259010202590
- 财政年份:2020
- 资助金额:$ 33.55万$ 33.55万
- 项目类别:
The circadian clock protein BMAL and post-translational regulation of ENaC in the kidney
肾脏中生物钟蛋白 BMAL 和 ENaC 的翻译后调节
- 批准号:1044027810440278
- 财政年份:2020
- 资助金额:$ 33.55万$ 33.55万
- 项目类别:
Calicum, MARCKS, and PIP2 regulation of ENaC
ENaC 的钙、MARCKS 和 PIP2 调节
- 批准号:87009588700958
- 财政年份:2014
- 资助金额:$ 33.55万$ 33.55万
- 项目类别:
Calicum, MARCKS, and PIP2 regulation of ENaC
ENaC 的钙、MARCKS 和 PIP2 调节
- 批准号:92835329283532
- 财政年份:2014
- 资助金额:$ 33.55万$ 33.55万
- 项目类别:
Calicum, MARCKS, and PIP2 regulation of ENaC
ENaC 的钙、MARCKS 和 PIP2 调节
- 批准号:92456999245699
- 财政年份:2014
- 资助金额:$ 33.55万$ 33.55万
- 项目类别:
Regulation of ENaC by phosphoinositides, MARCKS, and the cytoskeleton
磷酸肌醇、MARCKS 和细胞骨架对 ENaC 的调节
- 批准号:82033488203348
- 财政年份:2011
- 资助金额:$ 33.55万$ 33.55万
- 项目类别:
Regulation of ENaC by phosphoinositides, MARCKS, and the cytoskeleton
磷酸肌醇、MARCKS 和细胞骨架对 ENaC 的调节
- 批准号:83898288389828
- 财政年份:2011
- 资助金额:$ 33.55万$ 33.55万
- 项目类别:
相似海外基金
Contribution of Endothelial Planar Cell Polarity pathways in Blood Flow Direction Sensing
内皮平面细胞极性通路在血流方向传感中的贡献
- 批准号:1075069010750690
- 财政年份:2024
- 资助金额:$ 33.55万$ 33.55万
- 项目类别:
Mechanisms of Mammalian Genetic Hearing Loss
哺乳动物遗传性听力损失的机制
- 批准号:1066013410660134
- 财政年份:2023
- 资助金额:$ 33.55万$ 33.55万
- 项目类别:
Molecular Mechanisms of Myoblast Fusion
成肌细胞融合的分子机制
- 批准号:1092843810928438
- 财政年份:2023
- 资助金额:$ 33.55万$ 33.55万
- 项目类别:
Unmasking the Immunomodulatory Roles of CD7 Signaling
揭示 CD7 信号传导的免疫调节作用
- 批准号:1063787610637876
- 财政年份:2023
- 资助金额:$ 33.55万$ 33.55万
- 项目类别:
Increasing the Complexity of Microtubule-based transport: Cargo adaptors and Hitchhiking on Vesicles.
增加基于微管的运输的复杂性:货物适配器和囊泡搭便车。
- 批准号:1071344910713449
- 财政年份:2023
- 资助金额:$ 33.55万$ 33.55万
- 项目类别: